Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/26/3/523/16699096/mdu559.pdf
Reference24 articles.
1. Triple-negative breast cancer;Foulkes;N Engl J Med,2010
2. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network;Lin;Cancer,2012
3. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer;Zhang;Breast Cancer Res Treat,2012
4. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer;Atchley;J Clin Oncol,2008
5. Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women;Lee;J Clin Oncol,2011
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China;European Journal of Medical Research;2024-07-16
2. Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants;Breast Cancer Research and Treatment;2024-06-20
3. BRCA testing and management of BRCA-mutated early-stage breast cancer: a comprehensive statement by expert group from GCC region;Frontiers in Oncology;2024-04-25
4. Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response;Exploration of Targeted Anti-tumor Therapy;2024-02-28
5. AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3